CHEMED CORP - COM (CHE) Institutional Ownership

CUSIP: 16359R103

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / COM
Symbol
CHE on NYSE
Price per share
$396.63
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
13,832,224
Total reported value
$5,949,653,876
% of total 13F portfolios
0.01%
Share change
+81,523
Value change
+$31,478,426
Number of holders
513
Price from insider filings
$396.63
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 16359R103?
CUSIP 16359R103 identifies CHE - CHEMED CORP - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 513 institutional investors reported holding 13,832,224 shares of CHEMED CORP - COM (CHE).

Institutional Holders of CHEMED CORP - COM (CHE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 13,832,224 $5,949,653,876 +$31,478,426 $427.86 513
2025 Q3 13,731,270 $6,149,159,720 -$53,028,473 $447.74 518
2025 Q2 13,830,854 $6,749,405,268 +$59,315,114 $486.93 535
2025 Q1 13,607,107 $8,368,630,976 -$137,831,645 $615.32 551
2024 Q4 13,881,716 $7,353,637,634 -$203,892,605 $529.80 527
2024 Q3 14,079,344 $8,458,036,578 -$119,048,094 $600.97 524
2024 Q2 14,357,551 $7,789,616,670 -$25,768,652 $542.58 511
2024 Q1 14,374,520 $9,224,382,625 -$11,794,370 $641.93 505
2023 Q4 14,398,109 $8,418,109,427 +$28,773,602 $584.75 497
2023 Q3 14,344,866 $7,454,320,198 +$3,768,787 $519.70 454
2023 Q2 14,345,200 $7,768,834,915 +$198,502,796 $541.67 456
2023 Q1 13,924,907 $7,486,618,406 +$88,730,837 $537.75 453
2022 Q4 13,827,405 $7,057,305,938 +$154,997,326 $510.43 436
2022 Q3 13,693,041 $5,979,910,652 +$76,741,880 $436.56 408
2022 Q2 13,518,129 $6,346,344,088 +$88,120,687 $469.39 421
2022 Q1 13,410,756 $6,792,594,332 -$44,809,249 $506.55 411
2021 Q4 13,486,475 $7,130,610,198 -$277,711,837 $529.04 412
2021 Q3 13,997,382 $6,508,819,323 +$28,758,336 $465.12 398
2021 Q2 13,948,282 $6,617,570,075 -$181,919,034 $474.50 418
2021 Q1 14,345,765 $6,596,372,186 -$69,704,757 $459.82 415
2020 Q4 14,417,255 $7,677,325,857 +$94,334,041 $532.61 436
2020 Q3 14,266,876 $6,850,121,146 -$81,256,983 $480.35 441
2020 Q2 14,446,793 $6,518,265,047 +$60,798,147 $451.07 421
2020 Q1 14,319,069 $6,199,796,735 -$70,135,014 $433.20 409
2019 Q4 14,497,785 $6,370,535,090 +$20,097,373 $439.26 410
2019 Q3 14,410,779 $6,016,657,207 +$95,358,106 $417.57 392
2019 Q2 14,184,145 $5,119,933,080 +$52,739,645 $360.84 369
2019 Q1 14,138,087 $4,525,470,332 +$44,385,143 $320.07 378
2018 Q4 14,098,852 $3,994,162,521 -$38,066,924 $283.28 355
2018 Q3 14,207,888 $4,540,059,582 -$119,457,204 $319.58 348
2018 Q2 14,548,343 $4,681,453,138 -$198,931,985 $321.81 323
2018 Q1 15,182,881 $4,142,449,012 -$22,380,317 $272.86 285
2017 Q4 15,352,392 $3,729,167,268 -$99,874,098 $243.02 295
2017 Q3 15,745,084 $3,180,789,733 +$11,555,394 $202.05 257
2017 Q2 15,694,668 $3,210,112,332 -$41,629,160 $204.53 272
2017 Q1 15,902,981 $2,907,911,954 +$285,939,376 $182.69 248
2016 Q4 16,185,911 $2,596,465,981 +$19,472,216 $160.41 248
2016 Q3 16,088,006 $2,267,692,720 -$13,883,620 $141.07 239
2016 Q2 16,203,276 $2,209,659,911 -$3,767,521 $136.31 240
2016 Q1 16,340,647 $2,214,599,282 -$86,906,955 $135.45 233
2015 Q4 16,952,039 $2,539,699,183 -$47,034,473 $149.80 228
2015 Q3 17,268,625 $2,302,583,748 -$49,081,730 $133.47 211
2015 Q2 17,720,174 $2,323,150,102 -$18,499,785 $131.10 206
2015 Q1 17,876,421 $2,133,187,927 +$28,887,055 $119.40 199
2014 Q4 17,736,233 $1,874,073,965 -$123,789,512 $105.67 195
2014 Q3 18,793,111 $1,933,920,754 -$226,251,423 $102.90 192
2014 Q2 20,998,658 $1,968,720,609 -$120,770,123 $93.72 181
2014 Q1 22,321,609 $1,996,613,907 -$67,741,603 $89.45 192